SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sun Pharmaceutical Industries director resigns

03 Apr 2012 Evaluate

Sun Pharmaceutical Industries has informed that on account of increasing strategic importance of the group's business interests in North and South America, Kalyanasundaram Subramanian, now directly responsible for these businesses, shall soon relocate to the USA. Hence, he has resigned as the director of the company with effect from the March 31, 2012. 

The above information is part of company’s filing submitted to the BSE.

Sun Pharma Inds. Share Price

1786.90 7.55 (0.42%)
05-Jun-2026 10:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.90
Dr. Reddys Lab 1271.05
Cipla 1384.75
Zydus Lifesciences 1087.90
Lupin 2269.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×